Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night'
2023-01-10 07:00
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships
2023-01-10 07:00
Insilico Medicine Announces Positive Topline Results of the New Zealand Phase I Trial of INS018_055, an AI-Designed Drug for an AI-Discovered Target
2023-01-10 05:00
The Latest Global Survey from ISAPS Reports a Significant Rise in Aesthetic Surgery Worldwide
2023-01-10 00:16
Seoul Business Agency (SBA) Presents "Tech Hub Seoul" Vision in CES 2023 "Effectively inform the global stage about Seoul's technology and innovation"
2023-01-10 00:11
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes
2023-01-10 00:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy
2023-01-09 23:25
Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001
2023-01-09 22:00
Gift of Life Donor Program: Nation's Leader for 15 Years
2023-01-09 22:00
Mars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care
2023-01-09 21:15
FlatTech LLC Receives Innovative Technology Contract from Vizient for EpiFaith(R) Syringe for safer epidurals
2023-01-09 21:00
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia
2023-01-09 21:00
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
2023-01-09 20:00
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine
2023-01-09 20:00
Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong
2023-01-09 18:57
Ecolog International Appoints Juan Chaparro as Executive Director and Chairman of the Board
2023-01-09 17:00
CGTN: China downgrades COVID-19 rules as nation readies for normal life
2023-01-09 10:42
China welcomes first arrivals following downgraded COVID management
2023-01-09 07:40
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
2023-01-09 06:37
Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S
2023-01-08 14:17
1
213
214
215
216
217
1502